Biological composition, efficacy, and primary efficacy endpoint of SARS-CoV-2 vaccines; a special communication
Severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, in late December 2019 and rapidly spread out globally, affecting 130 million individuals and starting a global pandemic. An efficacious vaccine is considered an essential tool to reduce mortality and morbidity rate...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2022-10-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/4640 |